logo
ENTITY

Dogwood Therapeutics (DWTX US)

3
Analysis
Health Care • United States
Dogwood Therapeutics, Inc. operates as a development-stage biotechnology. The Company develops novel therapeutics and sodium channel blocker to treat moderate-to-severe chemotherapy induced neuropathic pain, cancer pain, and other pain indications. Dogwood Therapeutics serves patients in the United States.
more
bullish•Dogwood Therapeutics
•16 Oct 2024 09:40•Issuer-paid

Dogwood Therapeutics, Inc. - DWTX: Virios Therapeutics Becomes Dogwood Therapeutics

On October 7, 2024, Virios Therapeutics, Inc. (VIRI) announced a business combination with privately-held Wex Pharmaceuticals, Inc. to form Dogwood...

Logo
Share
bullish•Dogwood Therapeutics
•14 Aug 2024 00:00•Issuer-paid

VIRI: Enrollment Complete in Phase 2a Long COVID Trial Results Expected in October 2024

On August 8, 2024, Virios Therapeutics, Inc. (VIRI) announced financial results for the second quarter of 2024 and provided a business update. The...

Logo
Share
bullish•Dogwood Therapeutics
•14 May 2024 00:00•Issuer-paid

VIRI: Results for Phase 2 Long COVID Trial Expected in 2H24

On May 10, 2024, Virios Therapeutics, Inc. (VIRI) announced financial results for the first quarter of 2024 and provided a business update. The...

Logo
Share
No more insights

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.39.3

x